
Releases
Monteverde & Associates Probes AtaiBeckley Sale to Eli Lilly
Shareholders of AtaiBeckley Inc. face a proposed acquisition by Eli Lilly and Company that promises $6.75 per share in cash, supplemented by a $2.50 Contingent Value Right tied to the BPL-003 and VLS-01 development programs, prompting a formal investigation by the New York-based law firm Monteverde & Associates PC.























